Micro Labs Recalls Simvastatin Tablets Due to Impurity Failure
Micro Labs USA Inc. is recalling 13,464 bottles of Simvastatin 80mg tablets because the product failed a known impurity specification.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The agency classified this as an FDA Class III recall, which is defined as unlikely to cause adverse health consequences. The hazard is a failed impurity specification without reported illness, fitting the criteria for a moderate or low-risk precautionary recall.
Plain-English summary
Micro Labs USA Inc. is recalling 13,464 bottles of Simvastatin Tablets, USP, 80mg, Rx Only, 90 count bottles. The product was manufactured by Micro Labs Limited in India for Micro Labs USA Inc. in Princeton, NJ. The recall covers two specific lots: Lot STEG004 with an expiration date of 2/2015 and Lot STEG006 with an expiration date of 3/2015.
The recall was initiated because the product failed a known impurity specification. The affected bottles were distributed nationwide.
Consumers should stop using the recalled product and contact their healthcare provider or pharmacist for guidance on alternative treatment options. The source text does not report any illnesses or injuries associated with this recall.
The recalled product
- Product
- Simvastatin Tablets, USP, 80mg, Rx Only, 90 count bottles, Manufactured by: Micro Labs Limited Goa-403 722, India, Manufactured for: Micro Labs USA Inc., Princeton, NJ 08540 NDC 42571-080-90.
- Manufacturer
- Micro Labs Usa, Inc S
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 13,464
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: STEG004
- Exp 2/2015
- Lot #: STEG006 Exp 3/2015
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Micro Labs Usa, Inc S under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Micro Labs Usa, Inc S
See all →- LowMicro Labs Recalls Simvastatin Tablets Due to Impurity Failure
FDA (Drugs) · 2015-03-18
- ModerateMicro Labs Recalls Simvastatin Tablets Due to Impurity Failure
FDA (Drugs) · 2015-03-18
- SevereMicro Labs Recalls Losartan Potassium Tablets for Content Uniformity Failures
FDA (Drugs) · 2014-11-26
- LowMicro Labs Recalls Simvastatin Tablets Due to Impurity Specification Failure
FDA (Drugs) · 2014-11-19
- ModerateMicro Labs Recalls Glimepiride Tablets Due to Failed Stability Testing
FDA (Drugs) · 2014-11-05
Same hazard · impurity
See all →- ModerateAjanta Pharma Recalls Fluphenazine Hydrochloride Tablets Due to Impurity Failure
FDA (Drugs) · 2026-09-16
- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
Similar recalls
- LowMicro Labs Recalls Simvastatin Tablets Due to Impurity Specification Failure
FDA (Drugs) · 2014-11-19
- ModerateSimvastatin USP Tablets Recalled Due to Manufacturing Quality Deviations
FDA (Drugs) · 2023-05-10
- ModerateSimvastatin 40 mg recalled nationwide for manufacturing quality deviations
FDA (Drugs) · 2023-05-10
- HighSimvastatin Tablets, USP, 80 mg Recalled Due to Manufacturing Deviations
FDA (Drugs) · 2023-04-12
- SevereMicro Labs Recalls Losartan Potassium Tablets for Content Uniformity Failures
FDA (Drugs) · 2014-11-26
- HighDrug recall: Simvastatin 20 mg due to manufacturing control deviations
FDA (Drugs) · 2023-05-10